| ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers E Tacconelli, F Mazzaferri, AM de Smet, D Bragantini, P Eggimann, ... Clinical microbiology and infection 25 (7), 807-817, 2019 | 185 | 2019 |
| Anti-SARS-CoV-2 receptor-binding domain total antibodies response in seropositive and seronegative healthcare workers undergoing COVID-19 mRNA BNT162b2 vaccination GL Salvagno, BM Henry, G Di Piazza, L Pighi, S De Nitto, D Bragantini, ... Diagnostics 11 (5), 832, 2021 | 88 | 2021 |
| Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli L Scudeller, E Righi, M Chiamenti, D Bragantini, G Menchinelli, ... International journal of antimicrobial agents 57 (5), 106344, 2021 | 73 | 2021 |
| Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections E Concia, D Bragantini, F Mazzaferri Journal of Chemotherapy 29 (sup1), 19-28, 2017 | 53 | 2017 |
| Clinical assessment of the Roche SARS-CoV-2 rapid antigen test GL Salvagno, G Gianfilippi, D Bragantini, BM Henry, G Lippi Diagnosis 8 (3), 322-326, 2021 | 45 | 2021 |
| Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers GL Salvagno, BM Henry, G Di Piazza, L Pighi, S De Nitto, D Bragantini, ... Journal of Medical Biochemistry 40 (4), 327, 2021 | 24 | 2021 |
| The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies A Savoldi, E Carrara, LJV Piddock, F Franceschi, S Ellis, M Chiamenti, ... BMC Infectious Diseases 21 (1), 545, 2021 | 23 | 2021 |
| Combination versus monotherapy for the treatment of infections due to carbapenem-resistant Enterobacteriaceae E Carrara, D Bragantini, E Tacconelli Current opinion in infectious diseases 31 (6), 594-599, 2018 | 19 | 2018 |
| Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations E Carrara, A Savoldi, LJV Piddock, F Franceschi, S Ellis, M Sharland, ... Clinical Microbiology and Infection 28 (1), 66-72, 2022 | 15 | 2022 |
| A prediction rule for early recognition of patients with candidemia in Internal Medicine: results from an Italian, multicentric, case–control study E Sozio, F Pieralli, AM Azzini, G Tintori, F Demma, G Furneri, F Sbrana, ... Infection 46, 625-633, 2018 | 14 | 2018 |
| Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity GL Salvagno, L Pighi, BM Henry, M Valentini, B Tonin, D Bragantini, ... Clinical Chemistry and Laboratory Medicine (CCLM) 61 (7), 1343-1348, 2023 | 9 | 2023 |
| Clinical assessment of the Roche SARS-CoV-2 rapid antigen test. Diagnosis 2021 GL Salvagno, G Gianfilippi, D Bragantini, BM Henry, G Lippi | 6 | |
| Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naive patients with HIV-1 infection: An observational, retrospective, multi … S Rizzardo, M Lanzafame, E Lattuada, D Bragantini, S Nicolè, L Calza, ... International journal of STD & AIDS 30 (5), 467-471, 2019 | 2 | 2019 |
| Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab AC Comel, W Mosaner, D Bragantini, M Lanzafame Infection 49 (1), 195-196, 2021 | 1 | 2021 |
| Gammopatia monoclonale e infezione da SARS-CoV-2 L Pighi, S De Nitto, V Faccioli, M Valentini, D Bragantini, G Lippi, ... biochimica clinica 47 (2), e17, 2023 | | 2023 |
| Monoclonal gammopathy in SARS-CoV-2 infection L Pighi, S DE NITTO, F Vittorio, V Myriam, D Bragantini, G Lippi, ... BIOCHIMICA CLINICA 47 (2), e17-e20, 2023 | | 2023 |
| PharmaCovigilance: Role of the Pharmacist During COVID-19 Vaccination Campaign I Martignoni, D Bragantini, P Cicco, G Gianfilippi, M Gambera Drug Safety 45 (10), 1193-1193, 2022 | | 2022 |
| A novel logical model of COVID-19 intracellular infection to support therapies development E Piretto, G Selvaggio, D Bragantini, E Domenici, L Marchetti PLoS Computational Biology 18 (8), e1010443, 2022 | | 2022 |
| Clinical performance of Fujirebio Lumipulse G SARS-CoV-2 rapid antigen test L Pighi, S De Nitto, M Valentini, D Bragantini, G Gianfilippi, GL Salvagno, ... Biochimica Clinica, S147-S147, 2022 | | 2022 |
| Monocyte distribution width (MDW) in COVID-19: A pilot study L Pighi, S Denitto, D Bragantini, A Comel, W Mosaner, P Bazzoni, ... Biochimica Clinica, S117-S117, 2022 | | 2022 |
